Axcan Hires New VP Scientific Affairs and Announces Expansion of its Mont Saint-Hilaire Facilities.MONTREAL--(BUSINESS WIRE)--Sept. 8, 1997--AXCAN PHARMA (ME, TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :AXP) Axcan Pharma Inc., announced today the appointment of Dr. Francois Martin, MD, CSPQ, FRCP FRCP Fellow of the Royal College of Physicians. FRCP abbr. Fellow of the Royal College of Physicians (C), as Vice-President, Scientific Affairs. Dr. Martin will be responsible for all R&D activities relating to the Company's various products, including URSO(R) which is awaiting final approval from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for the treatment of Primary Biliary Cirrhosis Primary Biliary Cirrhosis Definition Primary biliary cirrhosis is the gradual destruction of the biliary system for unknown reasons. Description and which is also being tested for other indications. "We are delighted to have Dr. Martin join the Company. With his broad clinical experience and his extensive knowledge of gastroenterology, our R&D team will be ready for the challenges that lay ahead," said Mr. Leon F. Gosselin, Axcan's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . Dr. Francois Martin is a professor of medicine at the University of Montreal and a gastroenterologist at St-Luc Hospital in Montreal. Dr. Martin is a member of the Canadian Gastroenterology Association (CGA), the American Gastroenterology Association (AGA), the Royal College of Physicians The Royal College of Physicians of London was the first medical institution in England to receive a Royal Charter. It was founded in 1518 and is one of the most active of all medical professional organisations. of Canada and the International Organization for the Study of Inflammatory Bowel Disease inflammatory bowel disease n. Abbr. IBD Any of several incurable and debilitating diseases of the gastrointestinal tract characterized by inflammation and obstruction of parts of the intestine. (IOIBD). He is also a member of the editorial boards of the Canadian Journal of Gastroenterology and the Inflammatory Bowel Disease Journal. He has published over 50 research articles and has received the Academic and Scientific Excellence Award from the Quebec Gastroenterologists Association in 1995. In addition, Axcan announced that it has started the expansion of its Mont Saint-Hilaire facilities which will have nearly 9,000 feet of office space by the end of 1997. Axcan plans to hire 30 new employees in R&D, regulatory affairs, sales and marketing over the next three years. Axcan Pharma is a Canadian pharmaceutical company involved in the development and distribution of pharmaceutical products, mainly in the field of gastroenterology. The Company has nearly 100 employees at its head office in Mont St-Hilaire and its laboratory in Laval (Quebec). Axcan is one of the ten largest publicly traded health-care companies in Canada and is listed on the Montreal and Toronto Stock Exchanges under the symbol AXP. CONTACT: Axcan Pharma Inc. Bertrand Bolduc, 514/467-5138 Fax: 514/464-9979 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion